Albemarle Corporation

ALB · NYSE · USD

Financials

Annual

StatisticsIncome statementBalance sheetCash flowDividendsSegments

Valuation and market statistics · USD millions unless noted · ratios on the twelve months ending at each period

Line item	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009	FY2008	FY2007	FY2006	FY2005	FY2004	FY2003	FY2002	FY2001	FY2000	FY1999	FY1998	FY1997	FY1996	FY1995	FY1994	FY1993
Valuation
Market cap	$16,647	$10,118	$16,955	$25,406	$27,346	$17,256	$8,544	$9,015	$14,960	$10,069	$6,552	$4,732	$5,315	$5,540	$4,663	$5,098	$3,328	$2,037	$3,929	$3,397	$1,778	$1,609	$1,237	$1,198	$1,098	$1,136	$899	$1,225	$1,318	$1,067	$1,267	$901	$854
Enterprise value	$18,574	$12,779	$20,599	$27,431	$29,608	$20,399	$11,280	$10,339	$15,803	$10,316	$10,302	$5,306	$6,032	$5,860	$5,045	$5,489	$3,880	$2,716	$4,577	$3,980	$2,553	$2,508	$1,430	$1,351	$1,238	$1,215	$1,011	$1,397	$1,375	$1,085	$1,451	$1,126	$917
P/E (TTM) at period end	–	–	10.78×	9.45×	221.11×	45.92×	16.02×	13.00×	272.75×	15.64×	19.56×	35.49×	12.86×	17.78×	11.89×	16.14×	18.66×	10.49×	17.11×	23.76×	15.48×	29.35×	17.19×	16.41×	16.11×	11.16×	10.13×	14.46×	16.47×	6.84×	16.20×	17.57×	39.19×
P/S (TTM) at period end	3.24×	1.88×	1.76×	3.47×	8.22×	5.52×	2.38×	2.67×	4.87×	3.76×	2.32×	1.93×	2.22×	2.20×	1.76×	2.16×	1.66×	0.83×	1.68×	1.43×	0.84×	1.06×	1.11×	1.19×	1.17×	1.24×	1.06×	1.49×	1.59×	1.25×	1.02×	0.83×	0.95×
P/B at period end	1.75×	1.02×	1.80×	3.18×	4.86×	4.04×	2.17×	2.51×	4.07×	2.65×	2.01×	3.48×	3.27×	3.02×	2.93×	3.60×	2.76×	1.91×	3.07×	3.30×	1.91×	2.26×	1.94×	2.10×	1.85×	2.03×	1.83×	2.71×	2.55×	2.11×	2.04×	1.65×	1.22×
EV / EBITDA (TTM)	63.70×	–	30.21×	9.90×	28.13×	27.65×	12.82×	9.30×	20.56×	12.47×	17.02×	14.15×	8.82×	11.75×	8.18×	11.03×	13.53×	8.17×	10.85×	10.48×	9.05×	11.20×	8.09×	7.37×	7.03×	5.42×	5.04×	6.96×	7.24×	6.60×	6.87×	6.01×	6.69×
EV / Sales (TTM)	3.61×	2.38×	2.14×	3.75×	8.90×	6.52×	3.14×	3.06×	5.14×	3.85×	3.64×	2.17×	2.52×	2.33×	1.90×	2.32×	1.93×	1.10×	1.96×	1.68×	1.21×	1.66×	1.29×	1.34×	1.31×	1.32×	1.19×	1.70×	1.66×	1.27×	1.17×	1.04×	1.02×
Returns
Return on equity	(7.1%)	(13.2%)	16.7%	33.7%	2.2%	8.8%	13.6%	19.3%	1.5%	17.0%	10.3%	9.8%	25.4%	17.0%	24.6%	22.3%	14.8%	18.2%	18.0%	13.9%	12.3%	7.7%	11.3%	12.8%	11.5%	18.2%	18.1%	18.8%	15.5%	30.9%	12.6%	9.4%	3.1%
Return on invested capital	(3.2%)	(14.1%)	–	20.7%	7.9%	5.8%	8.4%	15.2%	0.4%	12.1%	4.8%	12.8%	18.5%	14.5%	20.6%	17.1%	10.6%	12.3%	13.4%	16.3%	7.9%	6.0%	9.4%	10.3%	9.4%	16.3%	14.3%	13.9%	13.9%	11.0%	8.6%	7.0%	3.3%
Dividend yield	1.1%	1.9%	1.1%	0.7%	0.7%	0.9%	1.8%	1.6%	0.9%	1.3%	1.8%	1.8%	1.5%	1.2%	1.2%	1.0%	1.3%	2.1%	1.0%	0.9%	1.5%	1.6%	2.1%	1.9%	2.2%	1.7%	2.1%	1.6%	1.3%	1.3%	1.1%	1.1%	–
Financial health
Current ratio	2.23×	1.95×	1.47×	1.89×	1.06×	1.22×	1.58×	1.69×	2.06×	2.90×	1.13×	2.94×	3.40×	3.66×	3.38×	3.70×	2.92×	2.68×	2.61×	1.99×	2.07×	2.00×	2.29×	2.50×	1.26×	2.22×	2.53×	2.89×	2.64×	1.75×	2.21×	2.15×	2.24×
Debt / equity	0.33×	0.35×	0.44×	0.40×	0.43×	0.84×	0.78×	0.48×	0.50×	0.62×	1.18×	2.16×	0.66×	0.38×	0.48×	0.61×	0.67×	0.87×	0.57×	0.71×	0.90×	1.33×	0.36×	0.33×	0.29×	0.18×	0.33×	0.43×	0.18×	0.06×	0.35×	0.47×	0.14×
Effective tax rate	(28.4%)	(4.9%)	174.4%	16.1%	22.0%	14.6%	15.7%	18.2%	96.6%	18.7%	3.6%	8.7%	25.0%	21.8%	21.7%	23.1%	(2.7%)	(3.6%)	18.2%	1.4%	18.4%	23.7%	15.8%	27.8%	29.9%	31.0%	31.0%	31.0%	33.8%	38.3%	40.6%	42.6%	48.7%
Share count
Diluted shares outstanding	118	118	118	118	117	107	106	109	112	113	112	79	84	90	92	92	92	93	97	97	95	85	84	86	93	93	95	104	111	118	133	130	118

StatisticsIncome statementBalance sheetCash flowDividendsSegments

Income statement · USD millions

Line item	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009	FY2008	FY2007	FY2006	FY2005	FY2004	FY2003	FY2002	FY2001	FY2000	FY1999	FY1998	FY1997	FY1996	FY1995	FY1994	FY1993
Revenue and gross profit
Revenue	$5,908	$5,143	$5,378	$9,617	$7,320	$3,328	$3,129	$3,589	$3,375	$3,072	$2,677	$2,826	$2,446	$2,394	$2,519	$2,652	$2,363	$2,005	$2,467	$2,336	$2,369	$2,107	$1,514	$1,110	$1,008	$943	$918	$846	$821	$830	$854	$1,244	$1,081	$903
Cost of revenue	($4,501)	($4,474)	($5,315)	($8,431)	($4,246)	($2,330)	($2,134)	($2,332)	($2,158)	($1,962)	($1,707)	($1,966)	($1,675)	($1,544)	($1,620)	($1,700)	($1,621)	($1,522)	($1,859)	($1,714)	($1,818)	($1,681)	($1,198)	($872)	($775)	($721)	($646)	($506)	($485)	($499)	($540)	($873)	($742)	($622)
Gross profit	$1,407	$669	$63	$1,186	$3,075	$998	$995	$1,258	$1,217	$1,106	$970	$860	$771	$850	$899	$952	$742	$484	$608	$622	$551	$426	$316	$239	$233	$221	$271	$340	$336	$330	$314	$371	$339	$281
Operating expenses
Research and development	($38)	($51)	($87)	($86)	($72)	($54)	($59)	($58)	($70)	($84)	($80)	($89)	($88)	($82)	($79)	($77)	($58)	($61)	($67)	($63)	($46)	($42)	($31)	($18)	($16)	($22)	($26)	($34)	($30)	($31)	($30)	($30)	($28)	–
Selling, general and administrative	($558)	($550)	($618)	($910)	($524)	($441)	($430)	($533)	($446)	($450)	($354)	($300)	($355)	($158)	($308)	($355)	($275)	($213)	($255)	($245)	($238)	($220)	($158)	($117)	($112)	($99)	($103)	($105)	($105)	($109)	($150)	($130)	($124)	($144)
Total operating expenses	($1,155)	($1,036)	($1,839)	($934)	($605)	($200)	($489)	($592)	($306)	($535)	($369)	($515)	($500)	($274)	($499)	($432)	($340)	($298)	($387)	($308)	($284)	($261)	($189)	($146)	($130)	($123)	($121)	($216)	($210)	($210)	($221)	($254)	($245)	($232)
Total costs and expenses	($5,656)	($5,510)	($7,154)	($9,365)	($4,850)	($2,530)	($2,623)	($2,923)	($2,463)	($2,500)	($2,076)	($2,481)	($2,174)	($1,818)	($2,119)	($2,132)	($1,961)	($1,819)	($2,246)	($2,021)	($2,102)	($1,943)	($1,387)	($1,017)	($905)	($844)	($767)	($721)	($695)	($709)	($761)	($1,127)	($987)	($855)
Operating income	$252	($367)	($1,777)	$252	$2,470	$798	$506	$666	$912	$572	$601	$345	$271	$577	$400	$520	$402	$186	$221	$315	$267	$165	$127	$93	$103	$98	$150	$125	$126	$121	$93	$117	$94	$49
Earnings
EBITDA	$894	$292	($1,188)	$682	$2,771	$1,052	$738	$880	$1,112	$769	$827	$605	$375	$684	$499	$617	$498	$287	$333	$422	$380	$282	$224	$177	$183	$176	$224	$201	$201	$190	$164	$211	$187	$137
Interest income	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Interest expense	($173)	($208)	($166)	($116)	($123)	($61)	($73)	($58)	($52)	($115)	($65)	($82)	($41)	($32)	($33)	($38)	($26)	($25)	($38)	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Pre-tax income	$172	($552)	($1,764)	$247	$2,433	$134	$374	$563	$795	$447	$515	$311	$213	$538	$368	$483	$379	$257	$183	$302	$158	$150	$72	$88	$101	$97	$148	$129	$123	$121	$253	$132	$89	$42
Income tax expense	($242)	($157)	($87)	($430)	($391)	($29)	($54)	($88)	($145)	($432)	($96)	($11)	($18)	($134)	($80)	($104)	($88)	$7	$7	($55)	($2)	($28)	($17)	($14)	($28)	($29)	($46)	($40)	($38)	($41)	($97)	($53)	($38)	($21)
Net income	$224	($511)	($1,179)	$1,573	$2,690	$124	$376	$533	$694	$55	$644	$335	$133	$413	$312	$392	$316	$178	$194	$230	$143	$115	$55	$72	$73	$68	$102	$89	$85	$80	$156	$78	$51	$22
Per share
Diluted EPS (GAAP)	$0.27	($5.76)	($11.20)	$13.36	$22.84	$1.06	$3.52	$5.02	$6.34	$0.49	$5.68	$3.00	$1.69	$4.90	$3.47	$4.28	$3.43	$1.94	$2.09	$2.36	$1.47	$1.20	$0.65	$0.86	$0.85	$0.74	$1.09	$0.94	$0.82	$0.72	$1.33	$0.59	$0.40	$0.19
Basic EPS (GAAP)	$0.48	($5.76)	($11.20)	$13.41	$22.97	$1.07	$3.53	$5.03	$6.40	$0.49	$5.73	$3.01	$1.69	$4.93	$3.49	$4.33	$3.46	$1.95	$2.12	$2.41	$1.51	$1.24	$0.66	$0.87	$0.87	$0.75	$1.11	$0.95	$0.82	$0.73	$1.33	$0.59	$0.40	$0.19
Basic shares outstanding	118	118	118	117	117	116	106	106	108	111	112	111	79	84	89	91	91	92	92	95	95	93	83	83	84	92	92	94	103	110	118	133	130	118
Margins
Gross margin	23.8%	13.0%	1.2%	12.3%	42.0%	30.0%	31.8%	35.0%	36.1%	36.0%	36.2%	30.4%	31.5%	35.5%	35.7%	35.9%	31.4%	24.1%	24.6%	26.6%	23.3%	20.2%	20.9%	21.5%	23.1%	23.5%	29.6%	40.2%	40.9%	39.8%	36.8%	29.8%	31.3%	31.1%
Operating margin	4.3%	(7.1%)	(33.0%)	2.6%	33.7%	24.0%	16.2%	18.6%	27.0%	18.6%	22.4%	12.2%	11.1%	24.1%	15.9%	19.6%	17.0%	9.3%	9.0%	13.5%	11.3%	7.8%	8.4%	8.4%	10.2%	10.4%	16.4%	14.8%	15.3%	14.6%	10.9%	9.4%	8.7%	5.4%
Net margin	3.8%	(9.9%)	(21.9%)	16.4%	36.7%	3.7%	12.0%	14.9%	20.6%	1.8%	24.0%	11.8%	5.5%	17.3%	12.4%	14.8%	13.4%	8.9%	7.9%	9.8%	6.0%	5.5%	3.6%	6.5%	7.2%	7.2%	11.1%	10.5%	10.3%	9.6%	18.3%	6.3%	4.7%	2.4%

Analyst consensus

Buy45 analysts

Bearish · 5 · Hold · 19 · Bullish · 21

Earnings history

	EPS	Estimate
Q3 2024	$-1.55	$-0.44	Miss
Q4 2024	$-1.09	$-0.60	Miss
Q1 2025	$-0.18	$-0.62	Beat
Q2 2025	$0.11	$-0.83	Beat
Q3 2025	$-0.19	$-0.86	Beat
Q4 2025	$-0.53	$-0.42	Miss
Q1 2026	$2.95	$1.19	Beat
Q2 2026	$3.75	$3.20	Beat

Peers

Company overview

IPO dateFeb 22, 1994

CEOJerry Kent Jr.

Employees7,800

SectorBasic Materials

IndustryChemicals - Specialty

CountryUS

ExchangeNew York Stock Exchange

Websitewww.albemarle.com

Albemarle Corporation stands as a global innovator, producing and distributing a diverse portfolio of engineered specialty chemicals. Its business operations are divided into three principal segments: Lithium, Bromine, and Catalysts. The Lithium division supplies a variety of lithium compounds, including lithium carbonate, hydroxide, and chloride, alongside critical reagents like butyllithium. These materials are vital for manufacturing lithium-ion batteries found in electric vehicles and consumer electronics, as well as for high-performance greases, thermoplastic elastomers used in tires and plastics, and as catalysts for chemical reactions, organic synthesis in areas like steroid chemistry, vitamins, and the pharmaceutical industry. This segment also delivers cesium products for chemical and pharmaceutical applications, zirconium, barium, and titanium for pyrotechnic devices such as airbag initiators, offers expert technical services for the safe handling of reactive lithium products, and provides recycling solutions for lithium-containing by-products. The Bromine segment focuses on bromine and bromine-based fire safety compounds. It produces an array of specialty chemicals, including elemental bromine, various bromides, and brominated powdered activated carbon, which are utilized in chemical synthesis, fluids for oil and gas drilling, mercury emission control, water purification, and food processing. Additionally, it provides tertiary amines, which serve as key ingredients in surfactants, biocides, and sanitizers. Finally, the Catalysts segment offers a range of catalytic agents, including those for hydroprocessing, isomerization, and alkylation, alongside fluidized catalytic cracking (FCC) catalysts and additives, as well as organometallics and curatives. Albemarle's products are integral to numerous industries, including energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection. Established in 1887, the company's headquarters are located in Charlotte, North Carolina.

Athenic provides research and information tools for educational purposes only and is not a registered investment adviser or broker-dealer. Nothing on this page is investment advice or a recommendation to buy or sell any security. Market data may be delayed. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal.